Evidence map›Paper›PMID 28028215›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Bax transmembrane domain interacts with prosurvival Bcl-2 proteins in biological membranes.

Vicente Andreu-Fernández, Mónica Sancho, Ainhoa Genovés, Estefanía Lucendo, Franziska Todt, Joachim Lauterwasser, Kathrin Funk, Günther Jahreis, Enrique Pérez-Payá, Ismael Mingarro and 2 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Multi-Omics Analysis of a Spontaneous Type 2 Diabetes Model inInternational journal of molecular sciences · 2026
    Article
  5. SARS-CoV-2 membrane protein biogenesis.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Biochemistry and biophysics reports · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Computational design of BclxL inhibitors that target transmembrane domain interactions.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Vicente Andreu-FernándezLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain.
Mónica SanchoLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain.
Ainhoa GenovésLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain.
Estefanía LucendoLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain.
Franziska TodtInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany.
Joachim LauterwasserInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany.
Kathrin FunkInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany.
Günther JahreisDepartment of Biochemistry/Biotechnology, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Enrique Pérez-PayáLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain.
Ismael MingarroDepartament de Bioquímica i Biologia Molecular, Estructura de Recerca Interdisciplinar en Biotecnología i Biomedicina, Universitat de València, 46100 Burjassot, Spain; morzaez@cipf.es Ismael.Mingarro@uv.es frank.edlich@biochemie.uni-freiburg.de.
Frank EdlichInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany; morzaez@cipf.es Ismael.Mingarro@uv.es frank.edlich@biochemie.uni-freiburg.de.
Mar OrzáezLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain; morzaez@cipf.es Ismael.Mingarro@uv.es frank.edlich@biochemie.uni-freiburg.de.
Centro de Investigacion Principe Felipe · ESUniversity of Freiburg · DEMartin Luther University Halle-Wittenberg · DEUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Bcl-2 (B-cell lymphoma 2) protein Bax (Bcl-2 associated X, apoptosis regulator) can commit cells to apoptosis via outer mitochondrial membrane permeabilization. Bax activity is controlled in healthy cells by prosurvival Bcl-2 proteins. C-terminal Bax transmembrane domain interactions were implicated recently in Bax pore formation. Here, we show that the isolated transmembrane domains of Bax, Bcl-x

Indexed as

ApoptosisApoptosis Regulatory Proteinsbcl-2-Associated X Proteinbcl-X ProteinCell Line, TumorCell MembraneEscherichia coliHCT116 CellsHumansMembrane ProteinsMitochondriaMitochondrial MembranesProtein BindingProtein DomainsApoptosis Regulatory Proteinsbcl-2-Associated X Proteinbcl-X ProteinMembrane ProteinsapoptosisBcl-2mitochondriaoligomerizationtransmembrane

Identifiers

PMID28028215
PMCPMC5240701
OpenAlexW2563775745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.